Clinical trials: Motion Sickness
Motion Sickness
Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Randomized, double-blind, placebo-controlled investigating the efficacy of tradipitant in the treatment of motion sickness.
- Trial name
- NCT03772340
- Testing
- Tradipitant
- Where
- United States
- Volunteers
- 126 people
- Sponsor
- Vanda Pharmaceuticals
Motion Sickness
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in subjects affected by motion sickness during travel
- Trial name
- NCT04327661
- Testing
- Tradipitant
- Where
- 7 sites in United States
- Volunteers
- 366 people
- Sponsor
- Vanda Pharmaceuticals
Motion Sickness
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in participants affected by motion sickness during travel
- Trial name
- NCT05903924
- Testing
- Tradipitant
- Where
- 5 sites in United States
- Volunteers
- 316 people
- Sponsor
- Vanda Pharmaceuticals
Motion Sickness
Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray
Part 1, the pharmacokinetic (PK) phase, will expand upon the pilot study conducted at Naval Medical Research Laboratory (NAMRL) and has the goal of determining bioavailability and time to Cmax in a larger representative sample.
- Trial name
- NCT02155309
- Testing
- Scopolamine
- Where
- United States
- Volunteers
- 63 people, healthy volunteers welcome
- Sponsor
- Repurposed Therapeutics, Inc.